Spyre Therapeutics
Jose Soto, MS, is an experienced clinical operations professional currently serving as the Senior Director of Clinical Operations at Spyre Therapeutics since October 2024. Prior to this role, Jose held the position of Senior Director of Clinical Operations at BridgeBio Oncology Therapeutics from May 2023 to October 2024 and previously served in various capacities at BridgeBio, culminating as Director of Clinical Operations from April 2020 to May 2023. Earlier in the career, Jose worked as Director of Clinical Operations at UNITY Biotechnology and held multiple roles at Gilead Sciences, from Clinical Program Manager to Senior Global Clinical Trials Manager. Jose's career began as a Clinical Research Associate at Emmes and Capital Clinical Research Associates, and as a Research Assistant at UChicago Medicine. Jose holds a Master of Science in Clinical Research Administration from The George Washington University and a Bachelor of Science in Biological Sciences from the University of Chicago.
This person is not in any teams
Spyre Therapeutics
Spyre Therapeutics combines best-in-class antibody engineering, rational therapeutic combinations, and precision immunology approaches to maximize efficacy, safety, and convenience of treatments for inflammatory bowel disease.